Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Payables: 2017-2023

Historic Payables for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $2.0 million.

  • Solid Biosciences' Payables rose 82.19% to $3.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $9.7 million, marking a year-over-year decrease of 28.89%. This contributed to the annual value of $2.0 million for FY2023, which is 37.25% down from last year.
  • Latest data reveals that Solid Biosciences reported Payables of $2.0 million as of FY2023, which was down 37.25% from $3.2 million recorded in FY2022.
  • Solid Biosciences' 5-year Payables high stood at $7.1 million for FY2019, and its period low was $2.0 million during FY2023.
  • For the 3-year period, Solid Biosciences' Payables averaged around $3.2 million, with its median value being $3.2 million (2022).
  • Its Payables has fluctuated over the past 5 years, first spiked by 93.01% in 2019, then plummeted by 54.04% in 2020.
  • Over the past 5 years, Solid Biosciences' Payables (Yearly) stood at $7.1 million in 2019, then slumped by 54.04% to $3.3 million in 2020, then soared by 36.32% to $4.5 million in 2021, then decreased by 27.45% to $3.2 million in 2022, then plummeted by 37.25% to $2.0 million in 2023.